Barbara Ink

1.6k citations
49 papers · 1.3k indexed · h-index 15
Topics
Psoriasis: Treatment and Pathogenesis (28 papers)Spondyloarthritis Studies and Treatments (27 papers)Autoimmune and Inflammatory Disorders Research (19 papers)

In The Last Decade

Barbara Ink

44 papers receiving 1.3k citations

Peers

Barbara Ink
Comparison fields: 5 of 81
  • Immunology 489
  • Molecular Biology 488
  • Rheumatology 354
  • Epidemiology 287
  • Virology 248
Replace Begoña Galocha with:
Begoña Galocha Spain
Pieter Spee Denmark
Rayk Behrendt Germany
Sabine Wittmann Germany
Helen Cumming Australia
J J O'Shea United States
Marilyn Diaz United States
Rafael Núñez United States
Thomas Friede Germany
Robert W. Maul United States
Barbara Ink relative to Begoña Galocha Spain Begoña Galocha's profile →
Citations per field
00.5×10.5×
Begoña Galocha · 1×
Citations per year

Countries citing papers authored by Barbara Ink

Since Specialization
Citations

This map shows the geographic impact of Barbara Ink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Ink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Ink more than expected).

Fields of papers citing papers by Barbara Ink

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Ink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Ink. The network helps show where Barbara Ink may publish in the future.

Co-authorship network of co-authors of Barbara Ink

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Ink. A scholar is included among the top collaborators of Barbara Ink based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Ink. Barbara Ink is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 0
4 1
5 4
6 18
7 3
8 30
9 3
10 1
11 1
12 1
13 6
14 27
15 6
16 95
17 104
18 110
19 8
20 170

About Barbara Ink

Barbara Ink is a scholar working on Rheumatology, Hematology and Immunology, having authored 49 papers that have together received 1.3k indexed citations. Recurring topics across this work include Psoriasis: Treatment and Pathogenesis (28 papers), Spondyloarthritis Studies and Treatments (27 papers) and Autoimmune and Inflammatory Disorders Research (19 papers). The work is most often cited by research in Virology (248 citations), Rheumatology (354 citations) and Immunology (489 citations). Barbara Ink has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include David J. Pickup, Wolfgang K. Joklik, Caroline A. Ray, Ronald T. Hay, Gérard I. Evan, Jason Coarse, Iain B. McInnes, Joseph F. Merola, Christopher T. Ritchlin and Alice B. Gottlieb. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026